Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The osmotic gradient between blood and dialysate refers to the difference in osmotic pressure (created mostly by glucose or other osmotic agents in the dialysate) across a semipermeable membrane, which drives the movement of water (ultrafiltration) from blood into the dialysate during dialysis. This principle is fundamental to both hemodialysis and peritoneal dialysis, ensuring removal of excess water from patients with renal failure. The effectiveness and safety of the gradient depend on careful regulation of dialysate composition, membrane properties, and flow rates[6][5][1][4].
Not directly applicable; however, *mechanistically*: - Osmotic agents (like glucose or icodextrin) are added to dialysate to create an osmotic gradient, pulling water from the blood across the membrane into the dialysate[6][7][5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic gradient between blood and dialysate.